Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 10351 - 10375 of 10872 in total
Brogidirsen is under investigation in clinical trial NCT05996003 (NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)).
Investigational
Matched Description: … Brogidirsen is under investigation in clinical trial NCT05996003 (NS-089/NCNP-02-201 in Boys With Duchenne …
PF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome, and Excessive Daytime Sleepiness.
Investigational
Matched Description: … PF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome …
XEN-D0501 is a tetrahydronaphthyl urea-based selective TRPV1 antagonist being investigated for the treatment of erythromelalgia.
Investigational
Matched Description: … is a tetrahydronaphthyl urea-based selective TRPV1 antagonist being investigated for the treatment of
A specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A.
Experimental
Matched Description: … A specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A. …
Hedera helix leaf extract allergenic extract is used in allergenic testing.
Experimental
Matched Description: … Hedera helix leaf extract allergenic extract is used in allergenic testing. …
Cyclic adenosine monophosphate (cAMP, cyclic AMP or 3'-5'-cyclic adenosine monophosphate) is a molecule that is important in many biological processes; it is derived from adenosine triphosphate (ATP).
Experimental
Matched Description: … monophosphate (cAMP, cyclic AMP or 3'-5'-cyclic adenosine monophosphate) is a molecule that is important in
Altrenogest, also known as allyltrenbolone, is a steroidal progestin that is widely used in veterinary medicine to suppress estrus in animals.
Vet approved
Matched Iupac: … hydroxy-11a-methyl-1-(prop-2-en-1-yl)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-cyclopenta[a]phenanthren-7- …
Matched Description: … medicine to suppress estrus in animals. ... Altrenogest, also known as allyltrenbolone, is a steroidal progestin that is widely used in veterinary …
BMS-830216 is under investigation in clinical trial NCT00909766 (Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects).
Investigational
Matched Description: … Study to Evaluate BMS-830216 in Obese Subjects). ... BMS-830216 is under investigation in clinical trial NCT00909766 (Safety, Pharmacokinetics and Pharmacodynamics …
Allisartan isoproxil is under investigation in clinical trial NCT03264352 (Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes).
Investigational
Matched Description: … Blood Pressure in Adults With Type 2 Diabetes). ... Allisartan isoproxil is under investigation in clinical trial NCT03264352 (Intervention for High-normal …
Bevonescein is under investigation in clinical trial NCT06227585 (Feasibility Study- REVEAL 475 for Bevonescein-assisted Nerve Visualization in Head & Neck Surgery).
Investigational
Matched Description: … Nerve Visualization in Head & Neck Surgery). ... Bevonescein is under investigation in clinical trial NCT06227585 (Feasibility Study- REVEAL 475 for Bevonescein-assisted …
Fleroxacin is a broad-spectrum antimicrobial fluoroquinolone. It strongly inhibits the DNA-supercoiling activity of DNA gyrase. Fleroxacin is not an inhibitor of CYP1A2.
Experimental
Matched Iupac: … 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Matched Description: … Fleroxacin is not an inhibitor of CYP1A2.[A39048] ... It strongly inhibits the DNA-supercoiling activity of DNA gyrase. …
EDI-200 is a fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the human receptor binding domain of ectodysplasin-A1.
Investigational
Matched Description: … human receptor binding domain of ectodysplasin-A1. ... EDI-200 is a fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the …
PCLX-001 is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by Pacylex Pharmaceuticals (https://pacylex.com). Current studies have shown that PCLX-001 works differently than other known cancer drugs and has high activity and positive results in breast, lung, bladder and pancreas cancers.
Investigational
Matched Description: … PCLX-001 is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by [Pacylex Pharmaceuticals ... PCLX-001 works differently than other known cancer drugs and has high activity and positive results in
Birinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).
Investigational
Matched Description: … Birinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic …
SCY-635 has been investigated for the treatment of Chronic Hepatitis C and Hepatitis C Infection.
Investigational
Matched Description: … SCY-635 has been investigated for the treatment of Chronic Hepatitis C and Hepatitis C Infection. …
DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein.
Investigational
Matched Description: … DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein. …
Suvodirsen is an antisense oligonucleotide that has been investigated for the treatment of Duchenne muscular dystrophy.
Investigational
Matched Description: … Suvodirsen is an antisense oligonucleotide that has been investigated for the treatment of Duchenne muscular …
PLG-0206 is a peptide antibiotic under investigation for the treatment of periprosthetic joint infections.
Investigational
Matched Description: … PLG-0206 is a peptide antibiotic under investigation for the treatment of periprosthetic joint infections …
MTL-CEBPA is a SMARTICLES liposomal formulation of MTL-501, a small activating RNA (saRNA) oligonucleotide.
Investigational
Matched Description: … MTL-CEBPA is a SMARTICLES liposomal formulation of MTL-501, a small activating RNA (saRNA) oligonucleotide …
Rugonersen is a locked nucleic acid antisense oligonucleotide under investigation for the treatment of Angelman Syndrome.
Investigational
Matched Description: … Rugonersen is a locked nucleic acid antisense oligonucleotide under investigation for the treatment of
Recombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).
Investigational
Matched Description: … Recombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating …
Flutriciclamide F-18 is under investigation in clinical trial NCT02350426 (A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques).
Investigational
Matched Description: … in Rheumatoid Arthritis Using Molecular Imaging Techniques). ... Flutriciclamide F-18 is under investigation in clinical trial NCT02350426 (A Study to Assess Inflammation …
Landipirdine is under investigation in clinical trial NCT02258152 (SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)).
Investigational
Matched Description: … , Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)). ... Landipirdine is under investigation in clinical trial NCT02258152 (SYN120 Study to Evaluate Its Safety …
DengueCide is a nonjugate of a dengue virus specific small chemical ligand and an amphiphilic PEG based polymer
Investigational
Matched Description: … DengueCide is a nonjugate of a dengue virus specific small chemical ligand and an amphiphilic PEG based …
A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine.
Vet approved
Matched Description: … A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine. …
Displaying drugs 10351 - 10375 of 10872 in total